MS.IR
PURDUE PHARMA
Quick answers
Is there a shortage of MS.IR in Canada?
No. There is no current shortage of MS.IR 20MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
STATEX
KNIGHT THERAPEUTICS INC.
MS.IR
PURDUE PHARMA
MS CONTIN
PURDUE PHARMA
M-ESLON
ETHYPHARM INC
M.O.S. SULPHATE 50MG TAB
VALEANT CANADA LP / VALEANT CANADA S.E.C.
ORAMORPH SR TABLETS 100MG
Extended-ReleaseROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
DIN
02014238
Strength
20MG
Dosage Form
Tablet (Immediate-Release)
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from PURDUE PHARMA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MCG · DIN 02465256
75MCG · DIN 02465221
150MCG · DIN 02465248
450MCG · DIN 02465264
10MCG · DIN 02341212
15MCG · DIN 02450771
20MCG · DIN 02341220
5MCG · DIN 02341174
100MG · DIN 02163748
150MG · DIN 02163780
200MG · DIN 02163799
50MG · DIN 02230302